Treatment of cells
AssigneeFundacion de Estudios Farmaco-Biologicos
InventorGregorio Ramon Cebrian
Life of this patent
Estimating the term…
Abstract
Method of treating virus disorders by administering 1,2-diphenyl-.alpha.,.beta.-diketone into the blood. Entry of this compound into the sick cells results in, because of the pH and redox-potential conditions in those cells, oxidation phenomena and deposition of an antiseptic substance in the sick cells, thereby causing cellular aging and necrosis.
Claims4
A method for selective cell necrosis, which comprises administering through the circulatory system to the altered cells of a patient having such altered cells a pharmaceutically effective amount of a composition containing 1,2-diphenyl-.alpha.,.beta.-diketone and a pharmaceutically suitable carrier therefor.
A method for selective cell necrosis, which comprises administering into the blood of a patient affected with altered cells, a pharmaceutically effective amount of 1,2-diphenyl-.alpha.,.beta.-diketone in the form of a solution in a pharmaceutically acceptable liposoluble medium suitable for internal administration.
A composition for achieving selective cell necrosis, comprising 1,2-diphenyl-.alpha.,.beta.-diketone and a pharmaceutically acceptable liposoluble medium, as carrier, suitable for internal administration.
Dependencies are inferred from the claim text.